DE1767499A1 - Verfahren zur Herstellung haltbarer Vitaminzubereitungen - Google Patents

Verfahren zur Herstellung haltbarer Vitaminzubereitungen

Info

Publication number
DE1767499A1
DE1767499A1 DE19681767499 DE1767499A DE1767499A1 DE 1767499 A1 DE1767499 A1 DE 1767499A1 DE 19681767499 DE19681767499 DE 19681767499 DE 1767499 A DE1767499 A DE 1767499A DE 1767499 A1 DE1767499 A1 DE 1767499A1
Authority
DE
Germany
Prior art keywords
parts
vitamin
durable
production
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19681767499
Other languages
German (de)
English (en)
Inventor
Eberhard Dr Nuernberg
Claus Dr Pich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to ES367284A priority Critical patent/ES367284A1/es
Priority to DE19681767499 priority patent/DE1767499A1/de
Priority to GB20481/69A priority patent/GB1201014A/en
Priority to IL32096A priority patent/IL32096A0/xx
Priority to AT435769A priority patent/AT285811B/de
Priority to CH669769A priority patent/CH522405A/de
Priority to SE06602/69A priority patent/SE357304B/xx
Priority to DK255869AA priority patent/DK122007B/da
Priority to NL6907431A priority patent/NL6907431A/xx
Priority to BR208845/69A priority patent/BR6908845D0/pt
Priority to FR6915928A priority patent/FR2008690A1/fr
Priority to BE733145D priority patent/BE733145A/xx
Publication of DE1767499A1 publication Critical patent/DE1767499A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19681767499 1968-05-16 1968-05-16 Verfahren zur Herstellung haltbarer Vitaminzubereitungen Pending DE1767499A1 (de)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ES367284A ES367284A1 (es) 1968-05-16 1968-05-16 Procedimiento para la obtencion de preparados de vitaminas solidos.
DE19681767499 DE1767499A1 (de) 1968-05-16 1968-05-16 Verfahren zur Herstellung haltbarer Vitaminzubereitungen
GB20481/69A GB1201014A (en) 1968-05-16 1969-04-22 Storage-stable vitamin preparations
IL32096A IL32096A0 (en) 1968-05-16 1969-04-29 Storage-stable vitamin compositions and their preparation
AT435769A AT285811B (de) 1968-05-16 1969-05-06 Verfahren zur Herstellung haltbarer Vitaminzubereitungen
CH669769A CH522405A (de) 1968-05-16 1969-05-07 Verfahren zur Herstellung haltbarer Vitaminzubereitungen
SE06602/69A SE357304B (xx) 1968-05-16 1969-05-09
DK255869AA DK122007B (da) 1968-05-16 1969-05-12 Fremgangsmåde til fremstilling af holdbare, faste vitaminpræparater.
NL6907431A NL6907431A (xx) 1968-05-16 1969-05-14
BR208845/69A BR6908845D0 (pt) 1968-05-16 1969-05-15 Processo para a producao de preparacoes de vitaminas conservaveis
FR6915928A FR2008690A1 (xx) 1968-05-16 1969-05-16
BE733145D BE733145A (xx) 1968-05-16 1969-05-16

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19681767499 DE1767499A1 (de) 1968-05-16 1968-05-16 Verfahren zur Herstellung haltbarer Vitaminzubereitungen

Publications (1)

Publication Number Publication Date
DE1767499A1 true DE1767499A1 (de) 1971-09-09

Family

ID=5699379

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19681767499 Pending DE1767499A1 (de) 1968-05-16 1968-05-16 Verfahren zur Herstellung haltbarer Vitaminzubereitungen

Country Status (12)

Country Link
AT (1) AT285811B (xx)
BE (1) BE733145A (xx)
BR (1) BR6908845D0 (xx)
CH (1) CH522405A (xx)
DE (1) DE1767499A1 (xx)
DK (1) DK122007B (xx)
ES (1) ES367284A1 (xx)
FR (1) FR2008690A1 (xx)
GB (1) GB1201014A (xx)
IL (1) IL32096A0 (xx)
NL (1) NL6907431A (xx)
SE (1) SE357304B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080673B1 (de) * 1981-11-28 1985-05-29 Roche Diagnostics GmbH Oral applizierte Zubereitungsformen von Guar-Mehl
US4721705A (en) * 1983-09-26 1988-01-26 Chemish Adviesbureau Drs. J.C.P. Schreuder B.V. Skin treatment compositions
DE4119306C2 (de) * 1991-06-12 1996-05-30 Wheli Inter Ag Organische Rohstoffe, Zwischen- und Endprodukte für die Ernährung und zur Verwendung für technische Zwecke, die Vitalstoffe enthalten
JPH06192105A (ja) * 1992-09-14 1994-07-12 Vesta Medicines Pty Ltd ホモシステインのレベルを下げるための医薬製剤
CA2105881A1 (en) 1992-09-14 1994-03-15 Willem Jacob Serfontein Compositions for the treatment and prophylaxis of metabolic disturbances in infants
DE19705555A1 (de) * 1997-02-13 1998-08-20 Ulrich Dr Posanski Pharmazeutische Präparate der Thioctsäure zur oralen Anwendung
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
DE60023125T2 (de) 1999-03-08 2006-06-22 University Of Manitoba, Winnipeg Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
EP1872797A3 (en) 1999-08-24 2008-04-02 Medicure International Inc. Treatment of cardiovascular and related pathologies
DE60110054T2 (de) 2000-02-29 2006-03-09 Medicure International Inc. Cardioprotektive phosphonate
AU784840B2 (en) 2000-03-28 2006-07-06 Medicure International Inc. Treatment of cerebrovascular disease
CN1095472C (zh) 2000-04-17 2002-12-04 上海复康医药科技发展有限公司 叶酸－多聚糖复合物，其制备方法和以该复合物为活性成分的药物组合物
WO2002004421A2 (en) 2000-07-07 2002-01-17 Medicure International Inc. Pyridoxine and pyridoxal analogues: cardiovascular therapeutics
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
CA2585165A1 (en) 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
WO2022005839A1 (en) 2020-06-30 2022-01-06 L'oreal Natural non-sulfate rinse-off cleansing compositions with high oil loading, and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2555463A (en) * 1949-03-28 1951-06-05 Parke Davis & Co Stabilized sodium pantothenate composition
FR1034595A (fr) * 1950-09-08 1953-07-27 Perfectionnements pour les traitements des hémicelluloses mannogalactanes, pour obtenir une imbibition retardée, propre aux fins thérapeutiques

Also Published As

Publication number Publication date
DK122007B (da) 1972-01-03
GB1201014A (en) 1970-08-05
ES367284A1 (es) 1971-04-01
SE357304B (xx) 1973-06-25
BE733145A (xx) 1969-11-17
NL6907431A (xx) 1969-11-18
IL32096A0 (en) 1969-06-25
FR2008690A1 (xx) 1970-01-23
CH522405A (de) 1972-05-15
AT285811B (de) 1970-11-10
BR6908845D0 (pt) 1973-02-08

Similar Documents

Publication Publication Date Title
DE1767499A1 (de) Verfahren zur Herstellung haltbarer Vitaminzubereitungen
DE69107046T2 (de) Algin enthaltende Nahrungsmittel und Getränke.
DE69031285T2 (de) Bakteriumwachstumsfördernde Substanz enthaltend Pullulan mit oder ohne Dextran
Platel et al. Stimulatory influence of select spices on bile secretion in rats
DE3406127C2 (xx)
EP0110170B1 (de) Honigpulver, in dem die natürlichen Aromastoffe erhalten bleiben, und Verfahren zu dessen Herstellung
DE69127456T2 (de) Gelatinkapseln substituiert durch stärke mit hohem amyloseanteil
DE69303813T2 (de) Gekörnte grundsätze enthaltende psyllium-getränkezusammenstellungen
DE69104901T2 (de) Orale Reis-Dextrin-Rehydratations-Lösung.
DE60031421T2 (de) Pflanzenextrakt-mischungen (cissus, vernonia, brillantaisia) und ihre verwendungen
WO2008058698A1 (de) Ballaststoff
DE3430799A1 (de) Verfahren zur behandlung von osteoporose
DE60002484T2 (de) Zusammensetzung die einen alpha-amylase inhibitor und mindestens eine physiologisch akzeptabele komponente, der die intestinale absorption von "fast sugars" reduzieren kann, enthält
DE60304723T2 (de) VERZWEIGTE ALPHA-GLUCANE FüR DAS GEWICHTSMANAGEMENT
WO1990011023A1 (de) Nahrungs- bzw. futterzusatzmittel
DE69934046T2 (de) Beta-glucooligosaccharide zur beschleunigung von calciumaufnahme
DE602004008737T2 (de) Chondroitinsulfat enthaltende Zusammensetzung
DE69310209T2 (de) Pryllium enthaltende zusammensetzung zur herstellung von getraenken
AT504489B1 (de) Süssstoffhaltige futtermittel und futtermittelzusätze
DE69533584T2 (de) Klinische Nährungszusammensetzung
DE2349186C2 (de) Arzneimittel zur Verbesserung der Zellatmung, der Herzmuskelleistung und der Hirnfunktion
DE1618696A1 (de) Verfahren zur Herstellung von Cholinsalicylat-Polygalacturonat
DE10352822A1 (de) Verwendung einer zusätzlich fermentierten Getreideschlempe zur Vorbeugung und/oder Behandlung erhöhter Blutzucker-Werte
CN115444878B (zh) 一种抑制公鸡打斗的天然组合物及其制备方法
WO2002069987A2 (de) Kombinationspräparat zur behandlung des diabetes mellitus